http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108484361-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a6a0fbfc7fd14c503cf84a903c0a2d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-46
filingDate 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc3495c857a006aface37976f164cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f67ce1a2ce2221249f456c30849c69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c437cbeac7ece47cb311d84a1f327a53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449e092830af049f5a2deb19b1bf8237
publicationDate 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108484361-A
titleOfInvention (S)-4-Chloro-1-(2,5)-difluorophenylbutan-1-ol and its preparation method and application
abstract The invention discloses (S)-4-chloro-1-(2,5)-difluorophenylbutan-1-alcohol and its preparation method and application, the (S)-4-chloro-1-(2 ,5)-difluorophenylbutan-1-alcohol has a chemical structure shown in formula I: The present invention utilizes cheap and easy-to-obtain raw material 4-chloro-1-(2,5)-difluorophenylbuta-1-one, and adopts biological enzyme method to synthesize (S)-4-chloro-1-(2,5 )-difluorophenylbuta-1-alcohol, and then utilize (S)-4-chloro-1-(2,5)-difluorophenylbutan-1-alcohol to synthesize the key intermediate of larotrectinib in two or three steps (R)-2-(2,5-difluorophenyl)pyrrolidine has the advantages of high yield, simple operation, low production cost, mild reaction conditions, etc., and has extremely strong practical value for realizing the industrialization of larotrectinib.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023082465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111333561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593802-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111057729-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111057729-A
priorityDate 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104672121-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108794370-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102482648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107207514-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466505189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452172045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93184079

Total number of triples: 34.